Advanced Search

    column
    Opportunities and Challenges of Nasal Drug Delivery
    LIAO Ping, CAO Meng, ZHANG Jingchen, CHEN Guiliang
    2023, 40(20): 2761-2765. DOI: 10.13748/j.cnki.issn1007-7693.20232901
    Abstract PDF
    Progress and Enlightenment of FDA Regulatory Science Research on Nasal Preparations
    LIAO Ping, GE Yuanyuan, CAO Meng, ZHAO Lu, JIA Guoshu, ZHANG Jingchen, CHEN Guiliang
    2023, 40(20): 2766-2773. DOI: 10.13748/j.cnki.issn1007-7693.20231873
    Abstract PDF
    Current Status and Regulatory Considerations of Drug-led Combination Products
    GE Yuanyuan, LIAO Ping, JIA Guoshu, LIANG Yan, ZHANG Jingchen, CHEN Guiliang, YUAN Hongmei
    2023, 40(20): 2774-2785. DOI: 10.13748/j.cnki.issn1007-7693.20231864
    Abstract PDF
    Analysis of FDA's Product-specific Guidances for Nasal Preparations
    LIAO Ping, GENG Ying
    2023, 40(20): 2786-2793. DOI: 10.13748/j.cnki.issn1007-7693.20231877
    Abstract PDF
    Nasal Delivery Device for “Nose-to-Brain”: Technical Discussion and Regulatory Considerations
    GONG Qianfei, MA Linsha, ZHENG Qiwen, WANG Jiajing
    2023, 40(20): 2794-2801. DOI: 10.13748/j.cnki.issn1007-7693.20232181
    Abstract PDF
    Advances and Challenges in Intranasal Biologics
    MA Linsha, JIA Guoshu, ZHOU Yimeng, CAO Meng, LIU Fen
    2023, 40(20): 2802-2810. DOI: 10.13748/j.cnki.issn1007-7693.20231878
    Abstract PDF
    Research Advances and Analysis of Excipients Used in Nasal Drugs New Approved by FDA
    FANG Xiaoyu, GE Yuanyuan
    2023, 40(20): 2811-2817. DOI: 10.13748/j.cnki.issn1007-7693.20232012
    Abstract PDF
    Effect of Suspending Agent Concentration on Spray Characteristics of Fluticasone Furoate Nasal Spray
    LYU Hang, CHEN Lan, SHAO Qi
    2023, 40(20): 2818-2826. DOI: 10.13748/j.cnki.issn1007-7693.20231892
    Abstract PDF
    Statistical Evaluation Methods and Considerations of Bioequivalence Studies for Nasal Sprays and Nasal Aerosols
    GENG Ying, LIAO Ping, DENG Yanping, WEI Ningyi, TAN Dejiang, YANG Quan, ZHOU Xuehai, XIE Shaofei, ZHU Rongdie, WANG Rui, CHEN Hua, CHEN Guiliang
    2023, 40(20): 2827-2837. DOI: 10.13748/j.cnki.issn1007-7693.20231945
    Abstract PDF
    Nasal Administration of NMFGF1 Loaded Nanoparticles Improved Cognitive Dysfunction in Vascular Dementia Mice
    ZHANG Ming, SUN Minyi, ZHU Ningwei, CHEN Mengjia, ZHAO Xichun
    2023, 40(20): 2838-2845. DOI: 10.13748/j.cnki.issn1007-7693.20231006
    Abstract PDF
    Optimization of Nasal Tissue Decalcification Technique in Preclinical Studies of Inhaled Drugs: Histopathological Examination of Nasal Mucosa in Rats
    WANG Yu, LAN Xiuhua, SHEN Bin, GAO Dan, FENG Zhen
    2023, 40(20): 2846-2850. DOI: 10.13748/j.cnki.issn1007-7693.20231880
    Abstract PDF
    Advance of Cell Model Methodology for Human Absorption Evaluation of Nasal Administration
    TAN Liwei, ZHANG Bin, SUN Xin, WANG Zhenyu
    2023, 40(20): 2851-2859. DOI: 10.13748/j.cnki.issn1007-7693.20231876
    Abstract PDF
    Analysis of Clinical Trials of Nasal Sprays Registration in China in the Past 10 Years
    ZHANG Wanjin, WANG Qian, LI Gang, ZHANG Jingchen
    2023, 40(20): 2860-2864. DOI: 10.13748/j.cnki.issn1007-7693.20231900
    Abstract PDF
    Research Progress of Intranasal Drug Delivery System for Treatment of Central Nervous System Diseases
    YANG Li, HOU Shuguang, ZHOU Xuan
    2023, 40(20): 2865-2871. DOI: 10.13748/j.cnki.issn1007-7693.20232209
    Abstract PDF
    Label Analysis of FDA Approved Nasal-brain Delivery Related Preparations
    ZHENG Qiwen, GAO Jing, MEI Leilei, CUI Xuezi, CHEN Yifei
    2023, 40(20): 2872-2877. DOI: 10.13748/j.cnki.issn1007-7693.20232527
    Abstract PDF
    Meta-analysis of the Safety of Esketamine Nasal Spray Add-on Therapy for Treatment-resistant Depression
    RAO Zhifang, TU Jing, CHENG Zhenlin
    2023, 40(20): 2878-2883. DOI: 10.13748/j.cnki.issn1007-7693.20224126
    Abstract PDF
    Protective Effect of Empagliflozin and Dapagliflozin on Palmitic Acid-induced Cardiomyocytes Injury and Its Underlying Mechanism
    WEI Yudi, LUO Shenhe, JIN Honghua
    2023, 40(20): 2884-2890. DOI: 10.13748/j.cnki.issn1007-7693.20223273
    Abstract PDF
    Improving Effect of Jianpi Yishen Huazhuo Recipe on Ovarian Function in Rats with Polycystic Ovary Syndrome Based on Bax/Bcl-2/Caspase-3 Pathway
    ZHANG Xiaojing, CHEN Miao, FENG Yahong, DU Xiaoli, JI Dejiang, MA Huiming
    2023, 40(20): 2891-2896. DOI: 10.13748/j.cnki.issn1007-7693.20223449
    Abstract PDF
    Research Progress in the Mechanisms of Tumor Translation Regulation and Their Therapeutic Targeting Options
    ZHENG Huimin, XU Yichen
    2023, 40(20): 2897-2908. DOI: 10.13748/j.cnki.issn1007-7693.20231604
    Abstract PDF